Increased expression of GAPDH is observed in several tumors such as prostate, breast, lung and cervical carcinomas, however, there is no alteration in expression in tumors such ashepatoma, colon cancer, lung adenocarcinoma and glioblastoma. Here, GAPDH is linked to malignant colon neoplasm.